Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15–25%, and 30 …

Esophageal cancer is a devastating malignancy which can be detected at an early stage but
is more often diagnosed as an advanced process. It affects both men and women and inflicts …

Esophageal adenocarcinoma (EAC) is the eighth most common cancer worldwide, and
approximately 15% of patients survive 5 years. Reflux disease (GERD) and Barrett's …

The incidence of esophageal adenocarcinoma is increasing largely in Western populations,
and patients diagnosed with this cancer continue to have a poor prognosis. The major risk …

Esophageal cancer (EC) is the ninth most common malignancy with a poor prognosis. It is
clear that improvements need to be made to reveal the exact molecular mechanisms of EC …

Simple Summary Esophageal cancer is one of the top ten most deadly cancers. Even when
diagnosed in a curable stage, patients prognosis poor. One of the parameters that is very …

Esophageal cancer is a deadly disease, ranking sixth among all cancers in mortality.
Despite incremental advances in diagnostics and therapeutics, esophageal cancer still …

Simple Summary Esophageal adenocarcinoma (EAC) is one of the two main subtypes of
esophageal cancer. EAC is a highly lethal disease with rising incidence in Western …

Introduction Esophageal cancer (EC) is a worldwide healthcare concern and represents an
aggressive malignancy. Squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) are …

Cancer-related inflammation is considered the 'seventh hallmark of cancer'; many studies
show that tumours develop and progress within inflammatory diseases. This review focuses …